ALDER BIOPHARMACEUTICALS INC Increase (Decrease) in Deferred Revenue
ALDER BIOPHARMACEUTICALS INC reported Increase (Decrease) in Deferred Revenue of -$54.32 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-02-23
- ALDER BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2014-12-31 was -$6.32M.
- ALDER BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2014-09-30 was -$38.70M.
- ALDER BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2014-06-30 was -$4.60M.
- ALDER BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2014-03-31 was -$4.70M.
- ALDER BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2014 was -$54.32M.
- ALDER BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2013 was -$18.25M.
- ALDER BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2012 was -$15.39M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$45.03M derived: sum of 2 quarters · filed 2017-02-23 | -$49.63M derived: sum of 3 quarters · filed 2017-02-23 | -$54.32M 10-K · filed 2017-02-23 |
| 2014-09-30 | -$38.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$43.31M derived: sum of 2 quarters · filed 2015-11-05 | -$48.00M 10-Q · filed 2015-11-05 | -$52.49M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$9.30M 10-Q · filed 2015-08-05 | -$13.79M derived: sum of 3 quarters · filed 2016-02-23 | -$18.44M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | -$4.70M 10-Q · filed 2015-05-07 | -$9.19M derived: sum of 2 quarters · filed 2016-02-23 | -$13.83M derived: sum of 3 quarters · filed 2016-02-23 | -$18.41M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | -$4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | -$9.14M derived: sum of 2 quarters · filed 2016-02-23 | -$13.72M derived: sum of 3 quarters · filed 2016-02-23 | -$18.25M 10-K · filed 2016-02-23 |
| 2013-09-30 | -$4.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | -$9.23M derived: sum of 2 quarters · filed 2014-11-03 | -$13.76M 10-Q · filed 2014-11-03 | |
| 2013-06-30 | -$4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$9.11M 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | -$4.53M 10-Q · filed 2014-06-20 | |||
| 2012-12-31 | -$15.39M 10-K · filed 2015-03-13 |